CLINICAL_TRIALS
trial_result
· 2018-04-20
Clinical Trial Update: A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial of LY2605541 in participants with Type 1 Diabetes Mellitus has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-04-20